![](/img/cover-not-exists.png)
Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Saâda-Bouzid, E., Defaucheux, C., Karabajakian, A., Palomar Coloma, V., Servois, V., Paoletti, X., Even, C., Fayette, J., Guigay, J., Loirat, D., Peyrade, F., Alt, M., Gal, J., Le Tourneau, C.Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx178
Date:
April, 2017
File:
PDF, 1.70 MB
english, 2017